Entrada Therapeutics, Inc. TRDA
5.25 USD +0.56 (+11.94%)
At closeNov 10, 2026, 4:47 PM EST
5.35 +0.10 +1.90%
After hours · Nov 10, 4:47 PM ET
4.64 Day range 5.29
4.11 52-week range 16.45
- YTD
- -48.93%
- 1 year
- -27.69%
TRDA revenue history
Revenue is income from the company’s ordinary business activities.
25,421,000 USD
FY 2025 · Period ended
Coverage: complete. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | 25,421,000 | -185,361,000 | -87.94% |
| FY 2024 | 2024-12-31 | 210,782,000 | 81,769,000 | 63.38% |
| FY 2023 | 2023-12-31 | 129,013,000 | 129,013,000 | Not meaningful |
| FY 2022 | 2022-12-31 | 0 | 0 | Not meaningful |
| FY 2021 | 2021-12-31 | 0 | 0 | Not meaningful |
| FY 2020 | 2020-12-31 | 0 | 0 | Not meaningful |
| FY 2019 | 2019-12-31 | 0 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-11-09T07:00:38.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.